Home
>>
Products
>>
Antibodies
>>
Recombinant Antibodies
>
Anti-Human CA9 Recombinant Antibody

Anti-Human CA9 Recombinant Antibody

Product Number

YR1222

Alias

科研级 Girentuximab ( 吉妥昔单抗 ), Anti-CA9 Recombinant Antibody, Research Grade Girentuximab

Specifications
  • 1mg
  • 5mg
Product Description
Alias科研级 Girentuximab ( 吉妥昔单抗 ), Anti-CA9 Recombinant Antibody, Research Grade Girentuximab
Catalog NumberYR1222
Molecular NameGirentuximab
HostMouse
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundGirentuximab (trade name Rencarex) is a chimeric IgG1 monoclonal antibody to carbonic anhydrase IX (CAIX). CAIX is expressed on the surface of most renal cancer cells and is hypothesized to be on the surface of other tumor cells. It is investigational agent in clinical trials for renal cell carcinoma. Its development was suspended as a "naked" or unconjugated antibody during phase III trials due to efficacy.
CAS Number916138-87-9
ApplicationWB, FuncS, IF, Neut, ELISA, FCM, IP, PK, IHC, Activ
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCA9[Homo sapiens]

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now